Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conbercept for BRVO-related macular edema
CTR20160178Phase 3Completed
- Sponsor
- Chengdu Kanghong Biotechnology Co., Ltd.
- Start
- Mar 2016
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of conbercept in branch retinal vein occlusion (BRVO), sponsored by Chengdu Kanghong Biotechnology Co., Ltd.. Started Mar 2016; status: completed.
02
Drugs
conbercept
03
Conditions
branch retinal vein occlusion (BRVO)
Beyond the preview
Go deeper on CTR20160178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160178.